Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Aug 26.
Published in final edited form as: Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;0(4):426–427. doi: 10.1002/ajmg.b.30295

The Fourth Apolipoprotein E Haplotype Found in the Yoruba of Ibadan

Jill R Murrell 1, Brandon M Price 1, Olusegun Baiyewu 2, Oye Gureje 2, Mark Deeg 3, Hugh Hendrie 4, Adesola Ogunniyi 2, Kathleen Hall 4
PMCID: PMC4550481  NIHMSID: NIHMS68207  PMID: 16583434

Apolipoprotein E (APOE) has a common polymorphism determined by variation at codon 112 and 158 resulting in three different haplotypes APOE ε2 (TT), APOE ε3 (TC), and APOE ε4 (CC). Due to the strong linkage disequilibrium between the two sites, normally three rather than four haplotypes are observed. While genotyping samples from the Indianapolis-Ibadan Dementia Project, a longitudinal, community-based study that seeks to identify risk factors for dementia in elderly African-Americans living in Indianapolis, Indiana, and in elderly Yoruba residing in Ibadan, Nigeria, the fourth APOE haplotype (CT) was discovered in a healthy 70 year-old Yoruba subject.

The local Institutional Review Boards have approved the study and informed consent was obtained from each participating individual. Genomic DNA was isolated from blood and APOE was genotyped as described [Hixson and Vernier 1990]. Amplified products resulting in an unusual HhaI pattern were sequenced. Serum was used to measure levels of various biomarkers. Lipoproteins were fractionated by gel filtration or agarose electrophoresis [Deeg et al., 2001].

A sample from a healthy 70 year-old Yoruba female gave a unique HhaI banding pattern (Fig. 1 available in supplementary data). The sequence showed a C at the first nucleotide of codon 112 in both alleles and a C and T at the first nucleotide of codon 158 (data not shown). One gene would code for apoE4 (Arg112-Arg158) and the other would code for a unique apoE protein (Arg112-Cys158). The subject’s 34 year-old son had the same genotype and her 67 year-old brother had an ε2/ε4 genotype (Fig. 2 available in supplementary data). Since the rare CT haplotype in combination with the frequent APOE ε3 TC haplotype would give an APOE ε2/ε4 HhaI digestion pattern and would not be distinguished by direct sequencing, all samples resulting in a ε2/ε4 genotype were digested with restriction enzymes AflIII and HaeII (New England Biolabs, Beverly, MA) [Chapman et al., 1996]. The CT haplotype was not found in the subject’s brother or the remaining samples from Ibadan and Indianapolis. In addition, the subject’s total cholesterol, triglycerides, LDL, HDL, folate insulin, glucose and TSH levels were all within normal limits. Fractionation of lipoproteins by gel filtration and agarose gel electrophoresis revealed a normal distribution of lipoproteins.

The CT haplotype has been reported once before (Genbank accession number AY077451) in an Italian autistic child and his normal mother and was named APOE ε3r because the cysteine and arginine are in reverse order (Arg112-Cys158) compared to apoE3 (Cys112-Arg158) [Persico et al., 2004]. We have decided to rename this haplotype APOE ε1Y because it would be the next haplotype counting backwards since ε4 is the ancestral haplotype. We added the Y for Yoruba to differentiate between the other ε1 proteins already described, which are ε2 or ε3 variants that contain mutations at different amino acids and run faster using protein electrophoresis [Ando et al., 1999; Gregg et al., 1983; Hoffer et al., 1996; Moriyama et al., 1992; Steinmetz et al., 1990; Weisgraber et al., 1984].

Supplementary Material

supp figs

Acknowledgments

This work was supported by National Institute of Aging grants R01 AG09956 and P30 AG10133.

References

  1. Ando M, Sasaki J, Hua H, Matsunaga A, Uchida K, Jou K, Oikawa S, Saito T, Nihei H. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy. Kidney Int. 1999;56(4):1317–23. doi: 10.1046/j.1523-1755.1999.00677.x. [DOI] [PubMed] [Google Scholar]
  2. Chapman J, Estupinan J, Asherov A, Goldfarb LG. A simple and efficient method for apolipoprotein E genotype determination. Neurology. 1996;46(5):1484–5. doi: 10.1212/wnl.46.5.1484-a. [DOI] [PubMed] [Google Scholar]
  3. Deeg MA, Bowen RF, Williams MD, Olson LK, Kirk EA, LeBoeuf RC. Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes. Am J Physiol Endocrinol Metab. 2001;281(1):E147–54. doi: 10.1152/ajpendo.2001.281.1.E147. [DOI] [PubMed] [Google Scholar]
  4. Gregg RE, Ghiselli G, Brewer HB., Jr Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia. J Clin Endocrinol Metab. 1983;57(5):969–74. doi: 10.1210/jcem-57-5-969. [DOI] [PubMed] [Google Scholar]
  5. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545–8. [PubMed] [Google Scholar]
  6. Hoffer MJ, Niththyananthan S, Naoumova RP, Kibirige MS, Frants RR, Havekes LM, Thompson GR. Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147--.Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia. Atherosclerosis. 1996;124(2):183–9. doi: 10.1016/0021-9150(96)05819-4. [DOI] [PubMed] [Google Scholar]
  7. Moriyama K, Sasaki J, Matsunaga A, Arakawa F, Takada Y, Araki K, Kaneko S, Arakawa K. Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia. Biochim Biophys Acta. 1992;1128(1):58–64. doi: 10.1016/0005-2760(92)90257-v. [DOI] [PubMed] [Google Scholar]
  8. Persico AM, D’Agruma L, Zelante L, Militerni R, Bravaccio C, Schneider C, Melmed R, Trillo S, Montecchi F, Elia M, Palermo M, Rabinowitz D, Pascucci T, Puglisi-Allegra S, Reichelt KL, Muscarella L, Guarnieri V, Melgari JM, Conciatori M, Keller F. Enhanced APOE2 transmission rates in families with autistic probands. Psychiatr Genet. 2004;14(2):73–82. doi: 10.1097/01.ypg.0000128768.37838.17. [DOI] [PubMed] [Google Scholar]
  9. Steinmetz A, Assefbarkhi N, Eltze C, Ehlenz K, Funke H, Pies A, Assmann G, Kaffarnik H. Normolipemic dysbetalipoproteinemia and hyperlipoproteinemia type III in subjects homozygous for a rare genetic apolipoprotein E variant (apoE1) J Lipid Res. 1990;31(6):1005–13. [PubMed] [Google Scholar]
  10. Weisgraber KH, Rall SC, Jr, Innerarity TL, Mahley RW, Kuusi T, Ehnholm C. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1. J Clin Invest. 1984;73(4):1024–33. doi: 10.1172/JCI111287. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supp figs

RESOURCES